Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety

Based on previous studies, 66 2-phenyl-4H-chromone derivatives containing amide and 1,3,4-oxadiazole moieties were prepared as potential telomerase inhibitors. The results showed most of the title compounds exhibited significantly inhibitory activity on telomerase. Among them, some compounds demonst...

Full description

Bibliographic Details
Main Authors: Xu Han, Yun Long Yu, Duo Ma, Zhao Yan Zhang, Xin Hua Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:http://dx.doi.org/10.1080/14756366.2020.1864630
_version_ 1818332571692433408
author Xu Han
Yun Long Yu
Duo Ma
Zhao Yan Zhang
Xin Hua Liu
author_facet Xu Han
Yun Long Yu
Duo Ma
Zhao Yan Zhang
Xin Hua Liu
author_sort Xu Han
collection DOAJ
description Based on previous studies, 66 2-phenyl-4H-chromone derivatives containing amide and 1,3,4-oxadiazole moieties were prepared as potential telomerase inhibitors. The results showed most of the title compounds exhibited significantly inhibitory activity on telomerase. Among them, some compounds demonstrated the most potent telomerase inhibitory activity (IC50 < 1 µM), which was significantly superior to the staurosporine (IC50 = 6.41 µM). In addition, clear structure–activity relationships were summarised, indicating that the substitution of the methoxy group and the position, type and number of the substituents on the phenyl ring had significant effects on telomerase activity. Among them, compound A33 showed considerable inhibition against telomerase. Flow cytometric analysis showed that compound A33 could arrest MGC-803 cell cycle at G2/M phase and induce apoptosis in a concentration-dependent way. Meanwhile, Western blotting revealed that this compound could reduce the expression of dyskerin, which is a fragment of telomerase.
first_indexed 2024-12-13T13:37:52Z
format Article
id doaj.art-7b4619047aa046dda50e031ee8716e87
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2024-12-13T13:37:52Z
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-7b4619047aa046dda50e031ee8716e872022-12-21T23:43:41ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742021-01-0136134536110.1080/14756366.2020.18646301864630Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moietyXu Han0Yun Long Yu1Duo Ma2Zhao Yan Zhang3Xin Hua Liu4School of Pharmacy, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical UniversitySchool of Pharmacy, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical UniversitySchool of Pharmacy, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical UniversitySchool of Pharmacy, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical UniversitySchool of Pharmacy, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical UniversityBased on previous studies, 66 2-phenyl-4H-chromone derivatives containing amide and 1,3,4-oxadiazole moieties were prepared as potential telomerase inhibitors. The results showed most of the title compounds exhibited significantly inhibitory activity on telomerase. Among them, some compounds demonstrated the most potent telomerase inhibitory activity (IC50 < 1 µM), which was significantly superior to the staurosporine (IC50 = 6.41 µM). In addition, clear structure–activity relationships were summarised, indicating that the substitution of the methoxy group and the position, type and number of the substituents on the phenyl ring had significant effects on telomerase activity. Among them, compound A33 showed considerable inhibition against telomerase. Flow cytometric analysis showed that compound A33 could arrest MGC-803 cell cycle at G2/M phase and induce apoptosis in a concentration-dependent way. Meanwhile, Western blotting revealed that this compound could reduce the expression of dyskerin, which is a fragment of telomerase.http://dx.doi.org/10.1080/14756366.2020.18646302-phenyl-4h-chromonesynthesistelomerase inhibitoranticancer activitydyskerin
spellingShingle Xu Han
Yun Long Yu
Duo Ma
Zhao Yan Zhang
Xin Hua Liu
Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety
Journal of Enzyme Inhibition and Medicinal Chemistry
2-phenyl-4h-chromone
synthesis
telomerase inhibitor
anticancer activity
dyskerin
title Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety
title_full Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety
title_fullStr Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety
title_full_unstemmed Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety
title_short Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety
title_sort synthesis telomerase inhibitory and anticancer activity of new 2 phenyl 4h chromone derivatives containing 1 3 4 oxadiazole moiety
topic 2-phenyl-4h-chromone
synthesis
telomerase inhibitor
anticancer activity
dyskerin
url http://dx.doi.org/10.1080/14756366.2020.1864630
work_keys_str_mv AT xuhan synthesistelomeraseinhibitoryandanticanceractivityofnew2phenyl4hchromonederivativescontaining134oxadiazolemoiety
AT yunlongyu synthesistelomeraseinhibitoryandanticanceractivityofnew2phenyl4hchromonederivativescontaining134oxadiazolemoiety
AT duoma synthesistelomeraseinhibitoryandanticanceractivityofnew2phenyl4hchromonederivativescontaining134oxadiazolemoiety
AT zhaoyanzhang synthesistelomeraseinhibitoryandanticanceractivityofnew2phenyl4hchromonederivativescontaining134oxadiazolemoiety
AT xinhualiu synthesistelomeraseinhibitoryandanticanceractivityofnew2phenyl4hchromonederivativescontaining134oxadiazolemoiety